ARTICLE | Company News
Amphora, JNJ inflammation deal
January 10, 2005 8:00 AM UTC
Amphora (Durham, N.C.) and Johnson & Johnson (JNJ) partnered to discover and develop treatments for inflammatory diseases. JNJ received exclusive rights to Amphora's compounds against an undisclosed i...